Skip to main content
. 2021 Dec 23;16:8309–8321. doi: 10.2147/IJN.S331909

Figure 9.

Figure 9

Analysis of cell cycle perturbation in HepG2 cell line following treatments with the prepared nanoformulations compared to untreated cells.